CAV1 and cancer: Further, F92A/V94A CSD mutation and cavtratin inhibit pCAV1-dependent cancer cell migration and focal adhesion tension26; deletion of the CSD prevents inhibition of HeLa cell migration by CAV1 overexpression35.